mXELOXIRI Combined With Molecular Targeted Drug in mCRC
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
The objective is to evaluate the efficacy and safety of modified XELOXIRI combined with molecular targeted drug as first-line therapy in patients with metastatic colorectal cancer (mCRC)
创建时间：
2019-07-15
